CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South

CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South

Source: 
Medical Marketing and Media
snippet: 

Additionally, CureVac has expanded its counterclaim against Pfizer and BioNTech to allege infringement of nine U.S. patents by the manufacturing and distribution of Comirnaty.